Skin ulceration potential of paclitaxel in a mouse skin model in vivo.
Bertelli
G
G
Cafferata
M A
MA
Ardizzoni
A
A
Gozza
A
A
Rosso
R
R
Dini
D
D
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D000077143:Docetaxel; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000188:drug therapy*; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D017239:Paclitaxel / Q000009:adverse effects / Q000031:analogs & derivatives; D012883:Skin Ulcer / Q000139:chemically induced*; D043823:Taxoids
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D006821:Hyaluronoglucosaminidase; D017239:Paclitaxel